SciSparc Ltd.
SPRC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001611746
No open-market purchases or sales by SciSparc Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $296.4K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in SciSparc Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 6
- −1 vs. Q2 2022
- Shares held
- 164.2K
- −309.2K (−65.3%) vs. Q2 2022
- Total value
- $129.5K
- −$877.5K (−87.1%) vs. Q2 2022
- New holders
- 3
- 1 more added
- Sold out
- 4
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SPRC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $296.4K |
| Q1 2026 | 3 | $12.0K |
| Q4 2025 | 7 | $78.1K |
| Q3 2025 | 5 | $47.0K |
| Q2 2025 | 6 | $35.3K |
| Q1 2025 | 6 | $19.9K |
| Q4 2024 | 9 | $47.2K |
| Q3 2024 | 5 | $29.7K |
| Q2 2024 | 6 | $66.9K |
| Q1 2024 | 2 | $22.0K |
| Q4 2023 | 2 | $36.1K |
| Q3 2023 | 3 | $514 |
| Q2 2023 | 6 | $95.1K |
| Q1 2023 | 9 | $102.9K |
| Q4 2022 | 3 | $88.2K |
| Q3 2022 | 6 | $129.5K |
| Q2 2022 | 7 | $1.01M |
| Q1 2022 | 5 | $530.0K |
| Q4 2021 | 3 | $705.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding SciSparc Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Phoenix Holdings Ltd. | 113,156 | $87.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,308 | $21.0K | 0.00% | +19,915+369.3% | Added |
| StoneX Group Inc. | 13,696 | $11.5K | 0.00% | +13,696 | New |
| Commonwealth Equity Services, LLC | 12,005 | $10.0K | 0.00% | +12,005 | New |
| Morgan Stanley | 2 | $0 | 0.00% | −38−95.0% | Reduced |
| Gradient Investments LLC | 75 | $0 | 0.00% | +75 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −335,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,807−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Ahrens Investment Partners LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |